Inventor · disambiguated record
Roger Smith
Also filed as: SMITH III ROGER · SMITH ROGER · SMITH ROGER A · SMITH ROGER ASTBURY
73 granted patents·61 pending applications·1,199 citations·filing 1987–2022
99Inventor score
Files withASANA BIOSCIENCES LLC31BAYER PHARMACEUTICALS CORP23BAYER HEALTHCARE LLC10BAYER AG8RIEDL BERND8
Top patents by PatentIndex Score
134 records- 0197US7235576B1Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Jun 26, 2007·94 cites·47 claims
- 0296US8101773B2Hydroxy methyl phenyl pyrazolyl urea compounds useful in the treatment of cancerSMITH ROGER·Filed 2007·Granted Jan 24, 2012·58 cites·16 claims
- 0396US7897623B2ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitorsBAYER HEALTHCARE LLC·Filed 2007·Granted Mar 1, 2011·35 cites·8 claims
- 0496US7625915B2Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureasBAYER HEALTHCARE LLC·Filed 2007·Granted Dec 1, 2009·33 cites·1 claims
- 0596US7528255B2Hydroxy, ω-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted May 5, 2009·35 cites·15 claims
- 0696US7351834B1ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsBAYER PHARMACEUTICALS CORP·Filed 2000·Granted Apr 1, 2008·64 cites·41 claims
- 0796US6187799B1Inhibition of raf kinase activity using aryl ureasONYX PHARMACEUTICALS·Filed 1998·Granted Feb 13, 2001·118 cites·18 claims
- 0895US6395282B1Immunogenic conjugates of Gram-negative bacterial autoinducer moleculesUNIV ROCHESTER·Filed 1999·Granted May 28, 2002·72 cites·7 claims
- 0994US8841330B2Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsRIEDL BERND·Filed 2012·Granted Sep 23, 2014·12 cites·14 claims
- 1094US7838524B2Substituted pyrazolyl urea derivatives useful in the treatment of cancerBAYER HEALTHCARE LLC·Filed 2005·Granted Nov 23, 2010·50 cites·37 claims
- 1194US7329670B1Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureasBAYER PHARMACEUTICALS CORP·Filed 1999·Granted Feb 12, 2008·76 cites·7 claims
- 1293US7384639B2Methods of treating or preventing an infectious disease using an immunogenic conjugate of a gram-negative bacterial autoinducer moleculeUNIV ROCHESTER·Filed 2005·Granted Jun 10, 2008·13 cites·4 claims
- 1393US5055451AAryloxy and arylacyloxy methyl ketones as thiol protease inhibitorsSYNTEX INC·Filed 1987·Granted Oct 8, 1991·83 cites·50 claims
- 1492US8124630B2ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitorsRIEDL BERND·Filed 2001·Granted Feb 28, 2012·27 cites·16 claims
- 1591US8207166B2Substituted pyrazolyl urea derivatives useful in the treatment of cancerLEE WENDY·Filed 2010·Granted Jun 26, 2012·24 cites·6 claims
- 1691US7371763B2Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureasBAYER PHARMACEUTICALS CORP·Filed 2005·Granted May 13, 2008·17 cites·37 claims
- 1790US11103491B2Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancerASANA BIOSCIENCES LLC·Filed 2020·Granted Aug 31, 2021·2 cites·12 claims
- 1890US6713059B2Antibodies raised against immunogenic conjugates of gram-negative bacterial autoinducer moleculesUNIV ROCHESTER·Filed 2002·Granted Mar 30, 2004·25 cites·17 claims
- 1988US6344476B1Inhibition of p38 kinase activity by aryl ureasBAYER AG·Filed 1998·Granted Feb 5, 2002·82 cites·18 claims
- 2087US6960601B2Preparation and use of imidazole derivatives for treatment of obesityBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Nov 1, 2005·26 cites·8 claims
- 2186US9382277B2Pyrimido-pyridazinone compounds and methods of use thereofASANA BIOSCIENCES LLC·Filed 2014·Granted Jul 5, 2016·8 cites·28 claims
- 2286US7517880B2Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureasBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Apr 14, 2009·25 cites·21 claims
- 2386US7511048B2PyrimidothienoindazolesBAYER PHARMACEUTICALS CORP·Filed 2005·Granted Mar 31, 2009·4 cites·10 claims
- 2486US7091228B2Preparation and use of aryl alkyl acid derivatives for the treatment of obesityBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Aug 15, 2006·18 cites·20 claims
- 2586US6660752B22,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Dec 9, 2003·24 cites·30 claims
- 2685US8809372B2Pyridine derivativesENDO PHARMACEUTICALS INC·Filed 2012·Granted Aug 19, 2014·3 cites·37 claims
- 2784US11434278B2Protein-polymer-drug conjugatesASANA BIOSCIENCES LLC·Filed 2019·Granted Sep 6, 2022·1 cites·4 claims
- 2884US10751332B2Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancerASANA BIOSCIENCES LLC·Filed 2016·Granted Aug 25, 2020·2 cites·7 claims
- 2984US7928239B2Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureasBAYER HEALTHCARE LLC·Filed 2001·Granted Apr 19, 2011·15 cites·18 claims
- 3083US8685418B2CyclohexylaminesENDO PHARMACEUTICALS INC·Filed 2012·Granted Apr 1, 2014·6 cites·1 claims
- 3182US10471051B2Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancerASANA BIOSCIENCES LLC·Filed 2017·Granted Nov 12, 2019·3 cites·38 claims
- 3282US10316080B2Protein-polymer-drug conjugatesASANA BIOSCIENCES LLC·Filed 2014·Granted Jun 11, 2019·4 cites·4 claims
- 3382US10188654B2Uses of pyrimido-pyridazinones to treat cancerASANA BIOSCIENCES LLC·Filed 2016·Granted Jan 29, 2019·3 cites·17 claims
- 3482US9896445B2Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancerASANA BIOSCIENCES LLC·Filed 2016·Granted Feb 20, 2018·3 cites·27 claims
- 3582US8729079B2Pyrimido-pyridazinone compounds and methods of use thereofVENKATESAN ARANAPAKAM·Filed 2012·Granted May 20, 2014·8 cites·25 claims
- 3682US5158936AAryloxy and arylacyloxy methyl ketones as thiol protease inhibitorsSYNTEX INC·Filed 1991·Granted Oct 27, 1992·44 cites·11 claims
- 3781US8440662B2Substituted quinazoline and pyrido-pyrimidine derivativesSMITH ROGER ASTBURY·Filed 2011·Granted May 14, 2013·9 cites·46 claims
- 3880US10647720B2Pyrimido-pyridazinone compounds and methods of use thereofASANA BIOSCIENCES LLC·Filed 2018·Granted May 12, 2020·1 cites·33 claims
- 3980US9499495B2Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathwaysASANA BIOSCIENCES LLC·Filed 2014·Granted Nov 22, 2016·4 cites·43 claims
- 4080US7928227B22-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disordersBAYER HEALTHCARE LLC·Filed 2004·Granted Apr 19, 2011·10 cites·28 claims
- 4179US7968576B2Preparation and use of aryl alkyl acid derivatives for the treatment of obesitySMITH ROGER A·Filed 2008·Granted Jun 28, 2011·3 cites·15 claims
- 4278US8076488B2Bicyclic urea derivatives useful in the treatment of cancer and other disordersDUMAS JACQUES·Filed 2004·Granted Dec 13, 2011·10 cites·32 claims
- 4376US11925629B2Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancerASANA BIOSCIENCES LLC·Filed 2021·Granted Mar 12, 2024·0 cites·14 claims
- 4474US7423156B2Preparation and use of aryl alkyl acid derivatives for the treatment of obesityBAYER PHARMACEUTICALS CORP·Filed 2006·Granted Sep 9, 2008·1 cites·20 claims
- 4574US2023183326A1Protein-polymer-drug conjugatesASANA BIOSCIENCES LLC·Filed 2022·Application pending·0 cites
- 4672US10183944B2Pyrimido-pyridazinone compounds and methods of use thereofASANA BIOSCIENCES LLC·Filed 2016·Granted Jan 22, 2019·1 cites·26 claims
- 4772US7750017B2HeterocyclesBAYER SCHERING PHARMA AG·Filed 2005·Granted Jul 6, 2010·2 cites·10 claims
- 4872US6699860B2Di-substituted aminomethyl-chroman derivative beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2001·Granted Mar 2, 2004·8 cites·20 claims
- 4972US2021113578A1Quinazolines and azaquinazolines as dual inhibitors of ras/raf/mek/erk and pi3k/akt/pten/mtor pathwaysASANA BIOSCIENCES LLC·Filed 2020·Application pending·0 cites
- 5070US10912779B2Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathwaysASANA BIOSCIENCES LLC·Filed 2019·Granted Feb 9, 2021·0 cites·23 claims
Showing the top 50 of 134 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Roger Smith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →